Table 2 Univariate and multivariate analysis of factors associated with failed thromboprophylaxis
From: Factors associated with venous thromboembolic disease due to failed thromboprophylaxis
Variable | Univariate analysis OR (95%CI) p value | Multivariate analysis OR (95%CI) p value | ||
|---|---|---|---|---|
BMI, kg/m2 | 1.05 (1.01–1.09) | 0.011 | 1.04 (1.00-1.09) | 0.039 |
Permanent central venous catheter | 1.01 (0.44–2.31) | 0.983 | - | - |
Active cancer | 1.01 (0.68–1.48) | 0.969 | 1.63 (1.03–2.57) | 0.036 |
History of VTE | 1.05 (0.39–2.85) | 0.911 | - | - |
Indication for hospitalization i0 | ||||
Medic Non-orthopedic surgical Orthopedic Surgical Neurosurgery | Reference 0.77(0.46–1.30) 0.49 (0.21–1.14) 1.25 (0.35–4.49) | 0.327 0.099 0.727 | - | - |
Surgery | 0.82 (0.53–1.27) | 0.371 | - | - |
Missed dose * | 1.26 (0.88–1.81) | 0.214 | - | - |
Leukocytosis | 1.68 (1.23–2.53) | 0.012 | 1.64 (1.05–2.57) | 0.031 |
Transfusion of blood products | 1.20 (0.78–1.84) | 0.418 | - | - |
No transfusion Packaged red blood cells Platelets Fresh frozen plasma Various | Referencia 1.32 (0.81–2.16) 0.41 (0.05–3.43) 0.99 (0.09–10.97) 1.09 (0.43–2-79 | 0.269 0.410 0.996 0.859 | - - - - - | - - - - - |
ICU requirement | 3.31 (2.23–4.90) | < 0.001 | 3.67 (2.31–5.83) | < 0.001 |
Infection with SARS COV 2 | 1.97 (1.36–2,87) | < 0.001 | - | - |